Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
67%
Ph phase_3
1
33%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 3Large-scale testing
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(1)
Other(2)

Detailed Status

unknown2
Completed1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (33.3%)
N/A2 (66.7%)

Trials by Status

completed133%
unknown267%

Recent Activity

0 active trials
Showing 3 of 3
completednot_applicable

Kidney Protection Using the RenalGuard® System in Cardiac Surgery

NCT02974946
unknownnot_applicable

Study to Evaluate the Use of RenalGuard to Protect Patients at High Risk of AKI

NCT02793661
unknownphase_3

RenalGuard System for Prevention of Contrast Induced Nephropathy

NCT02029820

Clinical Trials (3)

Showing 3 of 3 trials
NCT02974946Not Applicable

Kidney Protection Using the RenalGuard® System in Cardiac Surgery

Completed
NCT02793661Not Applicable

Study to Evaluate the Use of RenalGuard to Protect Patients at High Risk of AKI

Unknown
NCT02029820Phase 3

RenalGuard System for Prevention of Contrast Induced Nephropathy

Unknown

All 3 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
3